Quarterly Results

Q3 2022
STANDEX REPORTS FISCAL THIRD QUARTER 2022 FINANCIAL RESULTS
  • Order Strength, Share Gains, and Productivity Initiatives Contributed to Solid Financial Performance
  • Increased GAAP Operating Margin By 960 Basis Points and Adjusted Operating Margin By 160 Basis Points Year-Over-Year. Continued strong execution in challenging inflationary and supply chain environment
  • Implementing Additional $2 Million of Annualized Cost Saving Actions at the Engraving Segment
  • Announced New $100 Million Share Repurchase Authorization Supported by Strong Balance Sheet and Liquidity Position
  • Recent Sensor Solutions Acquisition Already Realizing Sales Synergies

SALEM, N.H., May 5, 2022 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) today reported financial results for the third quarter of fiscal year 2022 ending March 31, 2022.

 Summary Financial Results - Total Standex

                 

($M except EPS and Dividends)

3Q22

 

3Q21

 

2Q22

 

Y/Y

 

Q/Q

Net Sales

$189.3

 

$172.2

 

$185.7

 

9.9%

 

1.9%

Operating Income - GAAP

$24.5

 

$5.7

 

$21.8

 

333.1%

 

12.4%

Operating Income - Adjusted

$26.1

 

$21.0

 

$25.2

 

24.2%

 

3.4%

Operating Margin - GAAP

12.9%

 

3.3%

 

11.7%

 

+960 bps

 

+120 bps

Operating Margin - Adjusted

13.8%

 

12.2%

 

13.6%

 

+160 bps

 

+20 bps

Net Income from Continuing Ops - GAAP

$17.4

 

$1.8

 

$15.0

 

890.2%

 

15.8%

Net Income from Continuing Ops - Adjusted

$18.7

 

$14.6

 

$17.6

 

28.0%

 

5.7%

                   

EBITDA

$31.3

 

$13.7

 

$29.0

 

129.2%

 

8.1%

EBITDA margin

16.5%

 

7.9%

 

15.6%

 

+860 bps

 

+90 bps

Adjusted EBITDA

$33.0

 

$29.0

 

$32.5

 

13.5%

 

1.5%

Adjusted EBITDA margin

17.4%

 

16.9%

 

17.5%

 

+50 bps

 

-10 bps

                   

Diluted EPS - GAAP

$1.44

 

$0.14

 

$1.24

 

928.6%

 

16.1%

Diluted EPS - Adjusted

$1.54

 

$1.19

 

$1.45

 

29.4%

 

6.2%

Dividends per share

$0.26

 

$0.24

 

$0.26

 

8.3%

 

0.0%

                   

Free Cash Flow

$8.5

 

$12.4

 

$18.9

 

-31.1%

 

-55.0%

Net Debt to EBITDA

0.5x

 

0.8x

 

0.4x

 

-37.8%

 

21.4%

Third Quarter Fiscal 2022 Results  

Commenting on the quarter's results, President and Chief Executive Officer David Dunbar said, "Our momentum continues with very solid financial performance including record Electronics segment sales and consolidated adjusted operating margin.  In addition to solid execution on our growth strategy, ongoing price realization and productivity initiatives contributed to our earnings strength in the quarter. The consistent improvement in our financial results reflects the benefits of Standex's repositioned portfolio, increasingly aligned with sustainable global trends as we expand our range and penetration of innovative solutions.

"We continue to aggressively pursue new market opportunities, gaining further traction for applications in sectors with healthy growth prospects. Total company backlog realizable in under one year of approximately $267 million represented an approximately 51% increase year-over-year with strength at the Electronics, Specialty Solutions and Engraving segments and a slight overall increase sequentially. Our solar power project with Enel, a global energy company, continues to progress with the recent plant site selection in Brindisi, Italy for the pilot phase. Standex's strong balance sheet and steady cash flow generation provide substantial financial flexibility to further execute on our very active growth pipeline. 

"Despite the challenging operating environment, consolidated adjusted operating margin of 13.8% in fiscal third quarter 2022 represented a 160 basis point increase year-over-year and a 20 basis point improvement sequentially, primarily resulting from pricing and efficiency actions across the Company. We also acquired Sensor Solutions, providing us a very complementary sensor technology targeting high-value, growth markets and we are already seeing substantial sales synergies. We recently announced a new $100 million share repurchase authorization reinforcing the significant opportunity for further shareholder value creation. In addition, we declared our 231st consecutive quarterly dividend. Standex's financial position remains strong with approximately $300 million in available liquidity and a net debt to adjusted EBITDA ratio of approximately 0.5x at the end of the fiscal third quarter 2022," concluded Dunbar.

Outlook

In fiscal fourth quarter 2022, the Company expects a slight sequential decrease in revenue and operating margin, but an increase year-over-year. End market trends particularly in sectors such as electric vehicles, renewable energy, commercialization of space and defense remain strong, while food service equipment and commercial aviation continue to recover. However, the Company currently estimates the impact of the COVID-19 lockdown in China will defer sales of $7 million to $9 million from fiscal fourth quarter 2022.

As Standex enters fiscal 2023, the Company is well-positioned to grow as market trends remain strong, accelerated by an expanding new business opportunity funnel in fast growing end markets. The Company expects further margin improvement supported by continued effective management of inflationary trends, process improvements from additional operational excellence actions and ongoing G&A productivity initiatives.

Third Quarter Segment Operating Performance

Electronics (42% of sales; 55% of segment operating income)

 

3Q22

3Q21

% Change

Electronics ($M)

     

Revenue

$79.9

$65.1

22.7%

GAAP Operating Income

19.2

12.4

55.2%

GAAP Operating Margin

24.0%

19.0%

 

Adjusted Operating Income*          

19.2

12.4

55.5%

Adjusted Operating Margin*

24.1%

19.0%

 

*Excludes less than $0.1M of purchase accounting expenses associated with Sensor Solutions.

Revenue increased approximately $14.8 million or 22.7% year-over-year reflecting a 27.1% organic growth rate and a 0.6% contribution from the recent acquisition of Sensor Solutions partially offset by an approximately 5% impact from foreign exchange. Electronics segment backlog realizable in under one year increased 57% year-over-year and 5% sequentially to approximately $151 million.

Organic revenue growth was due to continued broad-based end market strength including increased demand for relays in renewable energy and electric vehicle applications and the impact of pricing actions. Adjusted operating income increased approximately $6.9 million or 55.5% year-over-year which reflected operating leverage associated with revenue growth, pricing, and productivity actions. Adjusted operating income excludes less than $0.1 million of purchase accounting expenses associated with the acquisition of Sensor Solutions.

In fiscal fourth quarter 2022, on a sequential basis, the Company expects a moderate decrease in revenue and operating margin primarily due to the impact of the COVID-19 lockdown in China partially offset by continued strong demand across key end markets.

Engraving (20% of sales; 16% of segment operating income)

 

3Q22

3Q21

% Change

Engraving ($M)

     

Revenue

$37.2

$36.0

3.3%

Operating Income

5.7

4.5

27.0%

Operating Margin

15.4%

12.5%

 

Revenue increased approximately $1.2 million or 3.3% year-over-year reflecting positive trends in North America and soft trim demand. Operating income increased $1.2 million or 27.0% year-over-year due to volume growth and the impact of efficiency and productivity actions. 

In fiscal fourth quarter 2022, the Company expects a slight sequential decrease in revenue and operating margin due to the timing of projects and geographic mix. In addition, the Company is implementing new cost savings and margin improvement actions targeting $2 million of annualized savings upon completion.

Scientific (10% of sales; 12% of segment operating income)

 

3Q22

3Q21

% Change

Scientific ($M)

     

Revenue

$18.9

$24.2

-21.9%

Operating Income               

4.2

5.8

-28.4%

Operating Margin

22.0%

24.0%

 

As expected, revenue decreased approximately $5.3 million or 21.9% year-over-year reflecting ongoing sales in pharmaceutical, clinical laboratories, and academic institution end markets offset by lower demand associated with COVID-19 vaccine storage. Operating income decreased approximately $1.6 million or 28.4% year-over-year due to the decrease in volume and higher freight costs partially offset by pricing actions.                                                                         

In fiscal fourth quarter 2022, on a sequential basis, the Company expects revenue to be similar and operating margin to decrease slightly due to product mix. 

Engineering Technologies (11% of sales; 7% of segment operating income)

 

3Q22

3Q21

% Change

Engineering Technologies ($M)          

     

Revenue

$20.9

$20.0

4.7%

Operating Income

2.3

1.2

86.9%

Operating Margin

11.1%

6.2%

 

Revenue increased approximately $0.9 million or 4.7% year-over-year due to continued growth in commercial aviation, defense, and medical end markets offset by the absence of the previously divested Enginetics business. Enginetics contributed approximately $3.9 million in revenue to fiscal third quarter 2021. Operating income grew approximately $1.1 million or 86.9% year-over-year reflecting volume growth and project mix. 

In fiscal fourth quarter 2022, the Company expects revenue to be sequentially similar to slightly higher with a slight to moderate increase in operating margin. This outlook reflects end market strength in commercial space and read out of productivity initiatives.

Specialty Solutions (17% of sales; 10% of segment operating income)

 

3Q22

3Q21

% Change

Specialty Solutions ($M)               

     

Revenue

$32.4

$26.9

20.2%

Operating Income

3.6

4.3

-14.6%

Operating Margin

11.2%

15.8%

 

Specialty Solutions revenue increased approximately $5.4 million or 20.2% year-over-year due to growth in food service equipment and refuse end markets. Operating income decreased approximately $0.6 million or 14.6% year-over-year reflecting the impact of material inflation and increased freight costs primarily in the Hydraulics business partially offset by volume growth and pricing actions.   

In fiscal fourth quarter 2022, the Company expects a slight sequential increase in revenue reflecting increased production levels at our Hydraulics business unit and solid demand in our display merchandising business. The Company expects a moderate improvement in operating margin compared to fiscal third quarter 2022 due to increased demand and productivity initiatives.

Capital Allocation

  • Share Repurchase: During the fiscal third quarter, the Company repurchased approximately 112,000 shares for $11.9 million. On May 5, 2022, Standex announced that its Board of Directors had authorized a new share repurchase program of up to $100 million following the completion of the $0.6 million remaining under the current share repurchase authorization at the end of the fiscal third quarter.

     
  • Capital Expenditures: In fiscal third quarter 2022, Standex's capital expenditures were $3.4 million compared to $5.4 million in the fiscal third quarter of 2021. Investments were focused on maintenance, safety, and the Company's highest priority growth initiatives. The Company expects fiscal year 2022 capital expenditures approximately $25 million.

     
  • Dividend:  On April 27, 2022, the Company declared a quarterly cash dividend of $0.26 per share, an approximately 8.3% year-over-year increase. The dividend is payable on May 25, 2022, to shareholders of record on May 11, 2022.

Balance Sheet and Cash Flow Highlights

  • Net Debt: Standex had net debt of $65.8 million on March 31, 2022, compared to $63.1 million at the end of fiscal 2021 and $82.1 million at the end of fiscal third quarter 2021. Net debt for the third quarter of 2022 consisted primarily of long-term debt of approximately $200 million and cash and equivalents of $133.9 million of which approximately $100.6 million held by foreign subsidiaries.

    Standex repatriated approximately $4.5 million in fiscal third quarter 2022 and $20.4 million in fiscal 2022. The company expects to repatriate between $30 million and $35 million in fiscal 2022.

     
  • Cash Flow:  Net cash provided by continuing operating activities for the three months ended March 31, 2022, was $11.9 million compared to net cash provided by continuing operating activities of $17.8 million in the prior year's quarter. The Company generated free cash flow after capital expenditures of $8.5 million compared to free cash flow after capital expenditures of $12.4 million in the fiscal third quarter of 2021. 

Conference Call Details

Standex will host a conference call for investors tomorrow, May 6, 2022, at 8:30 a.m. ET. On the call, David Dunbar, President, and CEO, and Ademir Sarcevic, CFO, will review the Company's financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located at www.standex.com.

A replay of the webcast will also be available on the Company's website shortly after the conclusion of the presentation online through May 6, 2023. To listen to the teleconference playback, please dial (877)-344-7529 in the U.S. or (412)-317-0088 internationally; the passcode is 6143696. The audio playback via phone will be available through May 13, 2022. The webcast replay can be accessed in the "Investor Relations" section of the Company's website, located at www.standex.com.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures including the impact of restructuring charges, purchase accounting, insurance recoveries, discrete tax events, loss on sale of a business unit, and acquisition costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods.  An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.  Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Brazil, Turkey, South Africa, India, and China. For additional information, visit the Company's website at http://standex.com/.

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as "should," "could," "may," "will," "expect," "believe," "estimate," "anticipate," "intend," "continue," or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company's business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics such as the current coronavirus on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; and potential changes to future pension funding requirements. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

 

Standex International Corporation

Consolidated Statement of Operations

     

(unaudited)

                 
                         
     

Three Months Ended

   

Nine Months Ended

     

March 31,

   

March 31,

(In thousands, except per share data)

   

2022

   

2021

   

2022

   

2021

                         

Net sales

 

$

189,281

 

$

172,216

 

$

550,600

 

$

479,797

Cost of sales

   

120,900

   

109,516

   

347,210

   

304,344

Gross profit

   

68,381

   

62,700

   

203,390

   

175,453

                         

Selling, general and administrative expenses

   

42,306

   

41,689

   

128,589

   

120,758

Loss on sale of business

   

-

   

14,624

   

-

   

14,624

Restructuring costs

   

1,186

   

482

   

2,469

   

2,478

Acquisition related costs

   

419

   

255

   

1,561

   

850

Other operating (income) expense, net

   

-

   

-

   

1,700

   

-

                         

Income from operations

   

24,470

   

5,650

   

69,071

   

36,743

                         

Interest expense

   

1,238

   

1,317

   

4,484

   

4,403

Other non-operating (income) expense, net

   

340

   

306

   

651

   

73

Total

   

1,578

   

1,623

   

5,135

   

4,476

                         

Income from continuing operations before income taxes

 

22,892

   

4,027

   

63,936

   

32,267

Provision for income taxes

   

5,484

   

2,269

   

15,677

   

8,155

Net income from continuing operations

   

17,408

   

1,758

   

48,259

   

24,112

                         

Income (loss) from discontinued operations, net of tax

   

(86)

   

(331)

   

(135)

   

(1,588)

                         

Net income

 

$

17,322

 

$

1,427

 

$

48,124

 

$

22,524

                         

Basic earnings per share:

                       

Income (loss) from continuing operations

 

$

1.45

 

$

0.14

 

$

4.02

 

$

1.98

Income (loss) from discontinued operations

   

(0.01)

   

(0.03)

   

(0.01)

   

(0.13)

Total

 

$

1.44

 

$

0.11

 

$

4.01

 

$

1.85

                         

Diluted earnings per share:

                       

Income (loss) from continuing operations

 

$

1.44

 

$

0.14

 

$

3.98

 

$

1.97

Income (loss) from discontinued operations

   

(0.01)

   

(0.03)

   

(0.01)

   

(0.13)

Total

 

$

1.43

 

$

0.11

 

$

3.97

 

$

1.84

                         

Average Shares Outstanding

                       

   Basic

   

11,982

   

12,136

   

12,009

   

12,185

   Diluted

   

12,089

   

12,253

   

12,121

   

12,267

 

Standex International Corporation

Condensed Consolidated Balance Sheets

(unaudited)

             
     

March 31,

   

June 30,

(In thousands)

   

2022

   

2021

             

ASSETS

           

Current assets:

           

  Cash and cash equivalents

 

$

133,902

 

$

136,367

  Accounts receivable, net

   

115,428

   

109,883

  Inventories

   

103,930

   

91,862

  Prepaid expenses and other current assets

   

41,800

   

23,504

  Income taxes receivable

   

15,584

   

12,750

    Total current assets

   

410,644

   

374,366

             

Property, plant, equipment, net

   

128,181

   

133,373

Intangible assets, net

   

91,545

   

98,929

Goodwill

   

275,127

   

278,054

Deferred tax asset

   

5,369

   

9,566

Operating lease right-of-use asset

   

35,558

   

37,276

Other non-current assets

   

27,144

   

30,659

    Total non-current assets

   

562,924

   

587,857

             

Total assets

 

$

973,568

 

$

962,223

             

LIABILITIES AND STOCKHOLDERS' EQUITY

         
             

Current liabilities:

           

  Accounts payable

 

$

75,275

 

$

74,756

  Accrued liabilities

   

57,185

   

61,717

  Income taxes payable

   

9,279

   

7,236

    Total current liabilities

   

141,739

   

143,709

             

Long-term debt

   

199,745

   

199,490

Operating lease long-term liabilities

   

28,683

   

29,041

Accrued pension and other non-current liabilities

   

75,781

   

83,558

    Total non-current liabilities

   

304,209

   

312,089

             

Stockholders' equity:

           

  Common stock

   

41,976

   

41,976

  Additional paid-in capital

   

88,197

   

80,788

  Retained earnings

   

891,303

   

852,489

  Accumulated other comprehensive loss

   

(121,870)

   

(116,140)

  Treasury shares

   

(371,986)

   

(352,688)

     Total stockholders' equity

   

527,620

   

506,425

             

Total liabilities and stockholders' equity

 

$

973,568

 

$

962,223

 

Standex International Corporation and Subsidiaries

         

Statements of Consolidated Cash Flows

         

(unaudited)

         
       

Nine Months Ended

       

March 31,

(In thousands)

     

2022

   

2021

               

Cash Flows from Operating Activities

             

Net income

 

$

 

48,124

 

$

22,524

Income (loss) from discontinued operations

     

(135)

   

(1,588)

Income from continuing operations

     

48,259

   

24,112

               

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

     

Depreciation and amortization

     

22,411

   

24,843

Stock-based compensation

     

8,213

   

5,658

Non-cash portion of restructuring charge

     

595

   

(538)

Loss on sale of business

     

-

   

14,624

Contributions to defined benefit plans

     

(157)

   

(7,962)

Net changes in operating assets and liabilities

     

(30,693)

   

(11,399)

Net cash provided by operating activities - continuing operations

     

48,628

   

49,338

Net cash provided by (used in) operating activities - discontinued operations

     

(375)

   

2,225

Net cash provided by (used in) operating activities

     

48,253

   

51,563

Cash Flows from Investing Activities

             

    Expenditures for property, plant and equipment

     

(13,138)

   

(15,612)

    Expenditures for acquisitions, net of cash acquired

     

(9,902)

   

(27,406)

   Proceeds from sale of business

     

-

   

11,678

    Other investing activities

     

5,718

   

(1,449)

Net cash (used in) investing activities

     

(17,322)

   

(32,789)

Cash Flows from Financing Activities

             

    Contingent consideration payment

     

(1,167)

   

-

    Activity under share-based payment plans

     

1,318

   

1,117

    Purchase of treasury stock

     

(21,420)

   

(16,205)

    Cash dividends paid

     

(9,148)

   

(8,547)

Net cash provided by (used in) financing activities

     

(30,417)

   

(23,635)

               

Effect of exchange rate changes on cash

     

(2,979)

   

4,092

               

Net changes in cash and cash equivalents

     

(2,465)

   

(769)

Cash and cash equivalents at beginning of year

     

136,367

   

118,809

Cash and cash equivalents at end of period

 

$

 

133,902

 

$

118,040

 

Standex International Corporation

Selected Segment Data

(unaudited)

                         
     

Three Months Ended

   

Nine Months Ended

     

March 31,

   

March 31,

(In thousands)

   

2022

   

2021

   

2022

   

2021

Net Sales

                       

Electronics

 

$

79,889

 

$

65,085

 

$

232,351

 

$

180,524

Engraving

   

37,223

   

36,026

   

109,037

   

110,377

Scientific

   

18,914

   

24,221

   

65,079

   

58,777

Engineering Technologies

   

20,890

   

19,951

   

56,558

   

55,091

Specialty Solutions

   

32,365

   

26,933

   

87,575

   

75,028

Total

 

$

189,281

 

$

172,216

 

$

550,600

 

$

479,797

                         

Income from operations

                       

Electronics

 

$

19,194

 

$

12,364

 

$

54,624

 

$

30,861

Engraving

   

5,728

   

4,510

   

15,806

   

16,884

Scientific

   

4,155

   

5,803

   

14,153

   

14,113

Engineering Technologies

   

2,327

   

1,245

   

5,540

   

3,076

Specialty Solutions

   

3,632

   

4,251

   

10,185

   

11,368

Restructuring

   

(1,186)

   

(482)

   

(2,469)

   

(2,478)

Loss on sale of business

   

-

   

(14,624)

   

-

   

(14,624)

Acquisition related costs

   

(419)

   

(255)

   

(1,561)

   

(850)

Corporate

   

(8,961)

   

(7,162)

   

(25,507)

   

(21,607)

Other operating income (expense), net 

   

-

   

-

   

(1,700)

   

-

Total

 

$

24,470

 

$

5,650

 

$

69,071

 

$

36,743

 

Standex International Corporation

   

Reconciliation of GAAP to Non-GAAP Financial Measures

   

(unaudited)

   
                                   
       

Three Months Ended

       

Nine Months Ended

   
       

March 31,

       

March 31,

   

(In thousands, except percentages)

   

2022

   

2021

 

%
Change

   

2022

   

2021

 

%
Change

Adjusted income from operations and adjusted
net income from continuing operations:

                               

Net Sales

 

$

189,281

 

$

172,216

 

9.9%

 

$

550,600

 

$

479,797

 

14.8%

Income from operations, as reported

 

$

24,470

 

$

5,650

 

333.1%

 

$

69,071

 

$

36,743

 

88.0%

 

Income from operations margin

   

12.9%

   

3.3%

       

12.5%

   

7.7%

   

Adjustments:

                               
 

Restructuring charges

   

1,186

   

482

       

2,469

   

2,478

   
 

Acquisition-related costs

   

419

   

255

       

1,561

   

850

   
 

Litigation charge

   

-

   

-

       

1,700

   

-

   
 

Loss on sale of business

   

-

   

14,624

       

-

   

14,624

   
 

Purchase accounting expenses

   

31

   

-

       

31

   

592

   

Adjusted income from operations

 

$

26,106

 

$

21,011

 

24.2%

 

$

74,832

 

$

55,287

 

35.4%

 

Adjusted income from operations margin

   

13.8%

   

12.2%

       

13.6%

   

11.5%

   
 

Interest and other income (expense), net

   

(1,578)

   

(1,623)

       

(5,135)

   

(4,476)

   
 

Provision for income taxes

   

(5,484)

   

(2,269)

       

(15,677)

   

(8,155)

   
 

Discrete and other tax items

   

-

   

-

       

-

   

(196)

   
 

Tax impact of above adjustments

   

(392)

   

(2,559)

       

(1,413)

   

(3,215)

   

Net income from continuing operations,
as adjusted

 

$

18,652

 

$

14,560

 

28.1%

 

$

52,607

 

$

39,245

 

34.0%

EBITDA and Adjusted EBITDA:

                               

Net income (loss) from continuing operations,
as reported

 

$

17,408

 

$

1,758

 

890.2%

 

$

48,259

 

$

24,112

   
 

Net income from continuing operations margin

   

9.2%

   

1.0%

       

8.8%

   

5.0%

   

Add back:

                               
 

Provision for income taxes

   

5,484

   

2,269

       

15,677

   

8,155

   
 

Interest expense

   

1,238

   

1,317

       

4,484

   

4,403

   
 

Depreciation and amortization

   

7,189

   

8,322

       

22,411

   

24,843

   

EBITDA

 

$

31,319

 

$

13,666

 

129.2%

 

$

90,831

 

$

61,513

 

47.7%

 

EBITDA Margin

   

16.5%

   

7.9%

       

16.5%

   

12.8%

   

Adjustments:

                               
 

Restructuring charges

   

1,186

   

482

       

2,469

   

2,478

   
 

Acquisition-related costs

   

419

   

255

       

1,561

   

850

   
 

Litigation charge

   

-

   

-

       

1,700

   

-

   
 

Loss on sale of business

   

-

   

14,624

       

-

   

14,624

   
 

Purchase accounting expenses

   

31

   

-

       

31

   

592

   

Adjusted EBITDA

 

$

32,955

 

$

29,027

 

13.5%

 

$

96,592

 

$

80,057

 

20.7%

 

Adjusted EBITDA Margin

   

17.4%

   

16.9%

       

17.5%

   

16.7%

   
                                   

Free cash flow:

                               

Net cash provided by operating activities -
continuing operations, as reported

 

$

11,929

 

$

17,830

     

$

48,628

 

$

49,338

   

Less: Capital expenditures

   

(3,417)

   

(5,466)

       

(13,138)

   

(15,612)

   

Free operating cash flow

 

$

8,512

 

$

12,364

     

$

35,490

 

$

33,726

   

 

Standex International Corporation

Reconciliation of GAAP to Non-GAAP Financial Measures

(unaudited)

                                   
       

Three Months Ended

       

Nine Months Ended

   

Adjusted earnings per share from continuing           
operations

   

March 31,

       

March 31,

   
   

2022

   

2021

 

%
Change

   

2022

   

2021

 

%
Change

                                   

Diluted earnings per share from continuing
operations, as reported

 

$

1.44

 

$

0.14

 

928.6%

 

$

3.98

 

$

1.97

 

102.0%

                                   

Adjustments:

                               
 

Restructuring charges

   

0.07

   

0.02

       

0.16

   

0.15

   
 

Acquisition-related costs

   

0.03

   

0.01

       

0.10

   

0.05

   
 

Litigation charge

   

-

   

-

       

0.10

   

-

   
 

Loss on sale of business

   

-

   

1.02

             

1.02

   
 

Discrete tax items

   

-

   

-

       

-

   

(0.02)

   
 

Purchase accounting expenses

   

-

   

-

       

-

   

0.04

   

Diluted earnings per share from continuing
operations, as adjusted

 

$

1.54

 

$

1.19

 

29.4%

 

$

4.34

 

$

3.21

 

35.2%

 

 

SOURCE Standex International Corporation

For further information: Ademir Sarcevic, CFO, (603) 893-9701; e-mail: InvestorRelations@Standex.com
Sign up for Alerts